AGP Limited informed Pakistan Stock Exchange that the Board of Directors of the Company held on June 19, 2020, the Board was briefed that the various inorganic growth and acquisition related investment opportunities are potentially available to the Company. After deliberation, the Board authorized the Company to evaluate these potential opportunities and conduct necessary feasibility studies, engage consultants, valuators and advisors as may be required from time to time.

The announcement is available at:

https://dps.psx.com.pk/download/document/149123.pdf

AGP Limited (AGP) began its commercial operations in 1989 as an independent pharmaceutical manufacturing company in Karachi, Pakistan. It has steadily grown through manufacturing and marketing products under licensing arrangements with many companies of international repute and also through manufacturing and marketing its own brands. Today, it is one of the largest pharmaceutical companies in Pakistan, providing a broad range of pharmaceutical products. The determination to upgrade the pharmaceutical resources of Pakistan and improvement of the quality of life of a common man was the key motivating factors in the inception of AGP.

The operations of AGP include manufacturing, marketing and sales of pharmaceuticals and healthcare products in the domestic and export market. The delivery of AGP's products, across the country, is managed by one of the largest and state of art pharmaceutical distribution set ups in Pakistan.

© Pakistan Press International, source Asianet-Pakistan